Microfluidic bioreactors offer several advantages for toxicology research. Firstly, they significantly reduce the amount of reagents and biological samples required, making experiments more cost-effective and ethical by minimizing the use of animal models. Secondly, they provide high-throughput screening capabilities, allowing researchers to evaluate numerous compounds simultaneously. This accelerates the discovery of toxic effects and the development of safer chemicals.
